Harold Bernstein sold $435K of MAZE stock

Harold Bernstein, President, R&D & CMO of Maze Therapeutics, Inc. (MAZE), sold 16,141 shares of MAZE stock worth $435K, per an SEC Form 4 filed Oct 2, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Oct 1, 2026, 1 day before it was made public.

MAZE has moved +35.4% since the trade date, from $26.65 to $36.09 (Nov 12, 2026 close).